1-14 of 14
Donald Buchsbaum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5915: ADT-1004: A promising pan-RAS inhibitor for targeting KRAS mutations in pancreatic ductal adenocarcinoma

Dhana Sekhar Reddy Bandi, Purnachandra Nagaraju Ganji, Sujith Sarvesh, Yulia Maxuitenko, Jeremy B Foote, Adam B Keeton, Xi Chen, Donald Buchsbaum, Gary Piazza, Bassel El-Rayes
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5915.
https://doi.org/10.1158/1538-7445.AM2024-5915
Published: 22 March 2024
View article titled, Abstract 5915: ADT-1004: A promising pan-RAS inhibitor for targeting KRAS mutations in pancreatic ductal adenocarcinoma
Journal Articles

Abstract 4677: Niclosamide analogs for treatment of ovarian cancer

Christen L. Walters Haygood, Rebecca C. Arend, Pui-Kai Li, Yonghe Li, Chandrika Kurpad, Abhishek Gangrade, John M. Straughn, Donald Buchsbaum
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4677.
https://doi.org/10.1158/1538-7445.AM2014-4677
Published: 01 October 2014
View article titled, Abstract 4677: Niclosamide analogs for treatment of ovarian cancer
Journal Articles

Abstract 641: Early therapy assessment of cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging

Hyunki Kim, Karri Folks, Lingling Guo, Jeffery Sellers, Naomi Fineberg, Cecil Stockard, William Grizzle, Donald Buchsbaum, Desiree Morgan, James George, Kurt Zinn
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 641.
https://doi.org/10.1158/1538-7445.AM10-641
Published: 15 April 2010
View article titled, Abstract 641: Early therapy assessment of cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging
Journal Articles

Abstract #1189: KiSS1 re-expression in pancreatic adenocarcinoma in a xenograft mouse model

Lacey McNally, Lewis Stafford, Danny Welch, Joshua Long, Jeffery Sellers, Zhi Huang, William Grizzle, Cecil Stockard, Donald Buchsbaum
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1189.
Published: 01 May 2009
View article titled, Abstract #1189: KiSS1 re-expression in pancreatic adenocarcinoma in a xenograft mouse model
Journal Articles

Abstract #1814: Voltage-gated sodium channel blockers for the treatment of prostate cancer cells by inhibiting cell migration, xenograft growth and sensitizing cells to radiation treatment

Hui Liu, Liming Fan, Donald Buchsbaum, Kevin Raisch
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1814.
Published: 01 May 2009
View article titled, Abstract #1814: Voltage-gated sodium channel blockers for the treatment of prostate cancer cells by inhibiting cell migration, xenograft growth and sensitizing cells to radiation treatment
Journal Articles

Differences in TRA-8 anti-DR5 antibody response with Adriamycin by modulation of Akt, cell cycle and apoptotic pathways.

Hope Amm, Donald Buchsbaum
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-228.
Published: 01 May 2008
View article titled, Differences in TRA-8 anti-DR5 antibody response with Adriamycin by modulation of Akt, cell cycle and apoptotic pathways.
Journal Articles

Design and development of novel non-toxic antitumor agents: synthesis and preliminary biological evaluation

Ajay Dixit, Sushma Mantena, Kevin Raisch, Leisa Sanford, James Bonner, Donald Buchsbaum, Hui-Yi Lin, Ahmad Safavy
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5683.
Published: 01 May 2008
View article titled, Design and development of novel non-toxic antitumor agents: synthesis and preliminary biological evaluation
Journal Articles

Early evaluation of a novel therapy with anti-DR5 antibody and chemotherapy in orthotopic pancreatic tumor xenografts using high field strength diffusion weighted imaging.

Hyunki Kim, Desiree Morgan, Donald Buchsbaum, Huadong Zeng, William Grizzle, Jason Warram, Cecil Stockard, Lacey McNally, Joshua Long, Jeffrey Sellers, Andres Forero, Kurt Zinn
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3722.
Published: 01 May 2008
View article titled, Early evaluation of a novel therapy with anti-DR5 antibody and chemotherapy in orthotopic pancreatic tumor xenografts using high field strength diffusion weighted imaging.
Journal Articles

Treatment of breast cancer cell line, MCF-7, with a novel topoisomerase II inhibitor

Hui Liu, Liming Fan, Bidhan Shinkre, Sadanandan Velu, Donald Buchsbaum, Kevin Raisch
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 779.
Published: 01 May 2008
View article titled, Treatment of breast cancer cell line, MCF-7, with a novel topoisomerase II inhibitor
Journal Articles

Pancreatic cancer ErbB3 pathway signaling is associated with improved patient survival and in vitro response to anti-EGFR therapy

Andrey Frolov, Ching-Wei Tzeng, Nirag Jhala, Natalya Frolova, Salwyn Vickers, Donald Buchsbaum, Martin Heslin, Juan Pablo Arnoletti
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-171.
Published: 01 May 2007
View article titled, Pancreatic cancer ErbB3 pathway signaling is associated with improved patient survival and <em>in vitro</em> response to anti-EGFR therapy
Journal Articles

Inducible Resistance of Tumor Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2–Mediated Apoptosis by Generation of a Blockade at the Death Domain Function

Yang Li, Hong Wang, Zheng Wang, Sharmila Makhija, Donald Buchsbaum, Albert LoBuglio, Robert Kimberly, Tong Zhou
Journal: Cancer Research
Cancer Res (2006) 66 (17): 8520–8528.
https://doi.org/10.1158/0008-5472.CAN-05-4364
Published: 01 September 2006
View article titled, Inducible Resistance of Tumor Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2–Mediated Apoptosis by Generation of a Blockade at the Death Domain Function
Open the PDF for Inducible Resistance of Tumor Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2–Mediated Apoptosis by Generation of a Blockade at the Death Domain Function in another window
Journal Articles

Survivin as a novel radiation/tissue specific promoter for adenovirus based gene therapy

Waleed O. Arafat, Donald Buchsbaum, Zeng Zhu, David Curiel
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 959.
Published: 01 April 2004
View article titled, Survivin as a novel radiation/tissue specific promoter for adenovirus based gene therapy
Journal Articles

Fractionated Radioimmunotherapy of Human Colon Carcinoma Xenografts with 131I-labeled Monoclonal Antibody CC49

Donald Buchsbaum, M. B. Khazaeli, Tiepu Liu, Sheila Bright, Kenneth Richardson, Margaret Jones, Ruby Meredith
Journal: Cancer Research
Cancer Res (1995) 55 (23_Supplement): 5881s–5887s.
Published: 01 December 1995
View article titled, Fractionated Radioimmunotherapy of Human Colon Carcinoma Xenografts with <sup>131</sup>I-labeled Monoclonal Antibody CC49
Open the PDF for Fractionated Radioimmunotherapy of Human Colon Carcinoma Xenografts with <sup>131</sup>I-labeled Monoclonal Antibody CC49 in another window
Journal Articles

Localization and Imaging of Radiolabeled Monoclonal Antibodies against Colorectal Carcinoma in Tumor-bearing Nude Mice

Donald Buchsbaum, Ricardo Lloyd, Jack Juni, Ira Wollner, Pamela Brubaker, David Hanna, Judith Spicker, Felissa Burns, Zenon Steplewski, David Colcher, Jeffrey Schlom, Franz Buchegger, Jean-Pierre Mach
Journal: Cancer Research
Cancer Res (1988) 48 (15): 4324–4333.
Published: 01 August 1988
View article titled, Localization and Imaging of Radiolabeled Monoclonal Antibodies against Colorectal Carcinoma in Tumor-bearing Nude Mice
Open the PDF for Localization and Imaging of Radiolabeled Monoclonal Antibodies against Colorectal Carcinoma in Tumor-bearing Nude Mice in another window